Future directions
Future work will focus on comparison of prospectively acquired KBR and 3DE datasets, to further validate the Ventripoint KBR platform and VMS+ 3.0 software as alternatives to atrial and ventricular volumes measured using MRI and 3DE. The availability of multiple validated analysis packages will encourage work in pediatric echocardiography that assesses 3DE volumetrics assessment as a prognostic and treatment indicator and may lead to inclusion of these parameters in future echocardiographic guidelines to aid in clinical decision making.